Engitix Therapeutics

0 followers


To create a healthier future for patients with life-threatening diseases, Engitix Therapeutics is using its pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumors.

Industries

Headquarters

Stage

Employees

Links

Org chart

Giuseppe Mazza
CEO & Co-Founder

Giuseppe Mazza

Collapse
David Dally
Chief Financial Officer
Chris Stevenson
Chief Scientific Officer
Alan Holmes
Vice President Fibrosis
Guy Nash
Senior Director, Intellectual Property
Dennis Norman
Senior Director, Drug Development & Operations
Thomas Gobbetti
Liver Fibrosis Progamme Leader And Director Of Translational Biology
Lisa Longato
Director Biology
Amélie Fortin
Director, People & Culture
Calum MacLeod
Director Of Medicinal Chemistry
John Prime
Director, Computational Biology
Luca Frenguelli
Director of Biomaterials
Maria Giovanna Vilia
Associate Director, HCC & Immuno-Oncology
Amy Lewis
Director, Fibrosis
Athiva Shankar
Associate Director, Biospecimens & Tissue-Based Assays